Skip to main content
Top
Published in: BMC Infectious Diseases 1/2017

Open Access 01-12-2017 | Research article

Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control

Authors: Gerit Korr, Michael Thamm, Irina Czogiel, Christina Poethko-Mueller, Viviane Bremer, Klaus Jansen

Published in: BMC Infectious Diseases | Issue 1/2017

Login to get access

Abstract

Background

Herpes simplex infections (HSV1/2) are characterized by recurrent symptoms, a risk of neonatal herpes, and the facilitation of HIV transmission. In Germany, HSV1/2 infections are not notifiable and data are scarce. A previous study found higher HSV1/2 seroprevalences in women in East Germany than in women in West Germany. We assessed changes in the HSV1/2 seroprevalences over time and investigated determinants associated with HSV1/2 seropositivity to guide prevention and control.

Methods

The study was based on the German Health Interview and Examination Survey for Adults (DEGS; 2008–2011) and the German National Health Interview and Examination Survey (GNHIES; 1997–1999). We tested serum samples from DEGS participants for HSV1 and HSV2 immunoglobulin G. We used Pearson’s χ2 test to compare the HSV1/HSV2 seroprevalences in terms of sex, age, and region of residence (East/West Germany) and investigated potential determinants by calculating prevalence ratios (PR) with log-binomial regression. All statistical analyses included survey weights.

Results

In total, 6627 DEGS participants were tested for HSV1, and 5013 were also tested for HSV2. Overall, HSV1 seroprevalence decreased significantly from 1997–1999 (82.1%; 95%CI 80.6–83.6) to 2008–2011 (78.4%; 95%CI 77.8–79.7). In the same period, overall HSV2 seroprevalence decreased significantly from 13.3% (95%CI 11.9–14.9) to 9.6% (95%CI 8.6–10.8), notably in 18–24-year-old men (10.4 to 0%) in East Germany. Women were more likely than men to be seropositive for HSV1 (PR 1.1) or HSV2 (PR 1.6). A lower level of education, smoking, and not speaking German were associated with HSV1 in both sexes. Women of older age, who smoked, or had a history of abortion and men of older age or who had not attended a nursery school during childhood were more often seropositive for HSV2.

Conclusion

The reduced seroprevalences of HSV1 and HSV2 leave more people susceptible to genital HSV1/2 infections. Practitioners should be aware of HSV infection as a differential diagnosis for genital ulcers. We recommend educational interventions to raise awareness of the sexual transmission route of HSV1/2, possible consequences, and prevention. Interventions should especially target pregnant women, their partners, and people at risk of HIV.
Literature
2.
go back to reference Steiner I, Kennedy PG. Herpes simplex virus latent infection in the nervous system. J Neurovirol. 1995;1(1):19–29.CrossRefPubMed Steiner I, Kennedy PG. Herpes simplex virus latent infection in the nervous system. J Neurovirol. 1995;1(1):19–29.CrossRefPubMed
3.
go back to reference Corey L, Spear PG. Infections with herpes simplex viruses (1). N Engl J Med. 1986;314(11):686–91.CrossRefPubMed Corey L, Spear PG. Infections with herpes simplex viruses (1). N Engl J Med. 1986;314(11):686–91.CrossRefPubMed
4.
go back to reference Garland SM, Steben M. Genital herpes. Best Pract Res Clin Obstetrics Gynaecol. 2014;28(7):1098–110.CrossRef Garland SM, Steben M. Genital herpes. Best Pract Res Clin Obstetrics Gynaecol. 2014;28(7):1098–110.CrossRef
5.
go back to reference Steiner I, Benninger F. Update on herpes virus infections of the nervous system. Curr Neurol Neurosci Rep. 2013;13(12):414.CrossRefPubMed Steiner I, Benninger F. Update on herpes virus infections of the nervous system. Curr Neurol Neurosci Rep. 2013;13(12):414.CrossRefPubMed
6.
go back to reference Salameh S, Sheth U, Shukla D. Early events in herpes simplex virus lifecycle with implications for an infection of lifetime. Open Virol J. 2012;6:1–6.CrossRefPubMedPubMedCentral Salameh S, Sheth U, Shukla D. Early events in herpes simplex virus lifecycle with implications for an infection of lifetime. Open Virol J. 2012;6:1–6.CrossRefPubMedPubMedCentral
7.
go back to reference Sundaram SS, Alderson S, Patel R. HSV-1 genital infection rare in men over the age of 35 years. Int J STD AIDS. 2009;20(1):68.CrossRefPubMed Sundaram SS, Alderson S, Patel R. HSV-1 genital infection rare in men over the age of 35 years. Int J STD AIDS. 2009;20(1):68.CrossRefPubMed
8.
go back to reference Chiam CW, Chan YF, Sam IC. Changing trends of genital herpes in Kuala Lumpur, Malaysia, 1982-2008. Int J STD AIDS. 2010;21(6):450–1.CrossRefPubMed Chiam CW, Chan YF, Sam IC. Changing trends of genital herpes in Kuala Lumpur, Malaysia, 1982-2008. Int J STD AIDS. 2010;21(6):450–1.CrossRefPubMed
9.
go back to reference Kortekangas-Savolainen O, Orhanen E, Puodinketo T, Vuorinen T. Epidemiology of genital herpes simplex virus type 1 and 2 infections in southwestern Finland during a 10-year period (2003-2012). Sex Transm Dis. 2014;41(4):268–71.CrossRefPubMed Kortekangas-Savolainen O, Orhanen E, Puodinketo T, Vuorinen T. Epidemiology of genital herpes simplex virus type 1 and 2 infections in southwestern Finland during a 10-year period (2003-2012). Sex Transm Dis. 2014;41(4):268–71.CrossRefPubMed
10.
go back to reference Copen CE, Chandra A, Martinez G. Prevalence and timing of oral sex with opposite-sex partners among females and males aged 15–24 years: United States, 2007–2010. Natl Health Stat Report. 2012(56):1–14. Copen CE, Chandra A, Martinez G. Prevalence and timing of oral sex with opposite-sex partners among females and males aged 15–24 years: United States, 2007–2010. Natl Health Stat Report. 2012(56):1–14.
11.
go back to reference Hofstetter AM, Rosenthal SL, Stanberry LR. Current thinking on genital herpes. Curr Opin Infect Dis. 2014;27(1):75–83.CrossRefPubMed Hofstetter AM, Rosenthal SL, Stanberry LR. Current thinking on genital herpes. Curr Opin Infect Dis. 2014;27(1):75–83.CrossRefPubMed
12.
go back to reference James SH, Kimberlin DW. Neonatal herpes simplex virus infection. Infect Dis Clin N Am. 2015;29(3):391–400.CrossRef James SH, Kimberlin DW. Neonatal herpes simplex virus infection. Infect Dis Clin N Am. 2015;29(3):391–400.CrossRef
13.
go back to reference Munawwar A, Singh S. Human Herpesviruses as Copathogens of HIV infection, their role in HIV transmission, and disease progression. J Lab Physicians. 2016;8(1):5–18.CrossRefPubMedPubMedCentral Munawwar A, Singh S. Human Herpesviruses as Copathogens of HIV infection, their role in HIV transmission, and disease progression. J Lab Physicians. 2016;8(1):5–18.CrossRefPubMedPubMedCentral
14.
go back to reference Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185(1):45–52.CrossRefPubMed Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis. 2002;185(1):45–52.CrossRefPubMed
15.
go back to reference Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10(10):e0140765.CrossRefPubMedPubMedCentral Looker KJ, Magaret AS, May MT, Turner KM, Vickerman P, Gottlieb SL, et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One. 2015;10(10):e0140765.CrossRefPubMedPubMedCentral
16.
go back to reference Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015;10(1):e114989.CrossRefPubMedPubMedCentral Looker KJ, Magaret AS, Turner KM, Vickerman P, Gottlieb SL, Newman LM. Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012. PLoS One. 2015;10(1):e114989.CrossRefPubMedPubMedCentral
17.
go back to reference Pebody RG, Andrews N, Brown D, Gopal R, De Melker H, Francois G, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect. 2004;80(3):185–91.CrossRefPubMedPubMedCentral Pebody RG, Andrews N, Brown D, Gopal R, De Melker H, Francois G, et al. The seroepidemiology of herpes simplex virus type 1 and 2 in Europe. Sex Transm Infect. 2004;80(3):185–91.CrossRefPubMedPubMedCentral
18.
go back to reference Hellenbrand W, Thierfelder W, Muller-Pebody B, Hamouda O, Breuer T. Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former east and West Germany, 1997-1998. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2005;24(2):131–5.CrossRef Hellenbrand W, Thierfelder W, Muller-Pebody B, Hamouda O, Breuer T. Seroprevalence of herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in former east and West Germany, 1997-1998. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology. 2005;24(2):131–5.CrossRef
19.
go back to reference Starke K, Visser AP. Sexuality, sexual behaviour and contraception in East Germany. Patient Educ Couns. 1994;23(3):217–26.CrossRefPubMed Starke K, Visser AP. Sexuality, sexual behaviour and contraception in East Germany. Patient Educ Couns. 1994;23(3):217–26.CrossRefPubMed
20.
go back to reference Bode H, Heßling A. Jugendsexualität 2015. Die Perspektive der 14-bis 25-Jährigen. Ergebnisse einer aktuellen Repräsentativen Wiederholungsbefragung. Köln: Bundeszentrale für gesundheitliche Aufklärung; 2015. Bode H, Heßling A. Jugendsexualität 2015. Die Perspektive der 14-bis 25-Jährigen. Ergebnisse einer aktuellen Repräsentativen Wiederholungsbefragung. Köln: Bundeszentrale für gesundheitliche Aufklärung; 2015.
21.
go back to reference Scheidt-Nave C, Kamtsiuris P, Goesswald A, Hoelling H, Lange M, Busch MA, et al. German health interview and examination survey for adults (DEGS)-design, objectives and implementation of the first data collection wave. BMC Public Health. 2012;12(1):730.CrossRefPubMedPubMedCentral Scheidt-Nave C, Kamtsiuris P, Goesswald A, Hoelling H, Lange M, Busch MA, et al. German health interview and examination survey for adults (DEGS)-design, objectives and implementation of the first data collection wave. BMC Public Health. 2012;12(1):730.CrossRefPubMedPubMedCentral
22.
go back to reference Thefeld W, Stolzenberg H, Bellach BM. The Federal Health Survey: response, composition of participants and non-responder analysis. Gesundheitswesen. 1999;61 Spec No:S57–61.PubMed Thefeld W, Stolzenberg H, Bellach BM. The Federal Health Survey: response, composition of participants and non-responder analysis. Gesundheitswesen. 1999;61 Spec No:S57–61.PubMed
23.
go back to reference Robbins G LW, Rompalo A, Riley L, Daskalakis D, Morrow R, Lee H, Shui S, Gaydos C, Detrick B, Rosenberg E, Crochiere D, Cunningham K, Bradley H, Markowitz L, Xu F, Felsenstein D. Serologic Assays for the Diagnosis of Herpes Virus 1 (HSV-1) Herpes Virus 2 (HSV-2): Test characteristics of FDA approved Type-Specific Assays in an Ethnically, Racially, and Economically Diverse Patient Population IDweek. San Diego: IDweek; 2015. Robbins G LW, Rompalo A, Riley L, Daskalakis D, Morrow R, Lee H, Shui S, Gaydos C, Detrick B, Rosenberg E, Crochiere D, Cunningham K, Bradley H, Markowitz L, Xu F, Felsenstein D. Serologic Assays for the Diagnosis of Herpes Virus 1 (HSV-1) Herpes Virus 2 (HSV-2): Test characteristics of FDA approved Type-Specific Assays in an Ethnically, Racially, and Economically Diverse Patient Population IDweek. San Diego: IDweek; 2015.
24.
go back to reference Maters AW, Wright CV, Lee MT, Schwichtenberg G, Detrick B. Detection of type-specific antibodies to HSV-1 and HSV-2: comparative analysis of a chemiluminescence immunoassay with a conventional ELISA. Diagn Microbiol Infect Dis. 2012;73(3):273–4.CrossRefPubMed Maters AW, Wright CV, Lee MT, Schwichtenberg G, Detrick B. Detection of type-specific antibodies to HSV-1 and HSV-2: comparative analysis of a chemiluminescence immunoassay with a conventional ELISA. Diagn Microbiol Infect Dis. 2012;73(3):273–4.CrossRefPubMed
25.
go back to reference Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010. J Infect Dis. 2014;209(3):325–33.CrossRefPubMed Bradley H, Markowitz LE, Gibson T, McQuillan GM. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010. J Infect Dis. 2014;209(3):325–33.CrossRefPubMed
26.
go back to reference Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect. 2000;76(3):183–7.CrossRefPubMedPubMedCentral Vyse AJ, Gay NJ, Slomka MJ, Gopal R, Gibbs T, Morgan-Capner P, et al. The burden of infection with HSV-1 and HSV-2 in England and Wales: implications for the changing epidemiology of genital herpes. Sex Transm Infect. 2000;76(3):183–7.CrossRefPubMedPubMedCentral
27.
go back to reference Davidovici BB, Grotto I, Balicer RD, Robinson NJ, Cohen D. Decline in the prevalence of antibodies to herpes simplex virus types 1 and 2 among Israeli young adults between 1984 and 2002. Sex Transm Dis. 2006;33(11):641–5.CrossRefPubMed Davidovici BB, Grotto I, Balicer RD, Robinson NJ, Cohen D. Decline in the prevalence of antibodies to herpes simplex virus types 1 and 2 among Israeli young adults between 1984 and 2002. Sex Transm Dis. 2006;33(11):641–5.CrossRefPubMed
28.
go back to reference Woestenberg PJ, Tjhie JH, de Melker HE, van der Klis FR, van Bergen JE, van der Sande MA, et al. Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period. BMC Infect Dis. 2016;16:364.CrossRefPubMedPubMedCentral Woestenberg PJ, Tjhie JH, de Melker HE, van der Klis FR, van Bergen JE, van der Sande MA, et al. Herpes simplex virus type 1 and type 2 in the Netherlands: seroprevalence, risk factors and changes during a 12-year period. BMC Infect Dis. 2016;16:364.CrossRefPubMedPubMedCentral
30.
go back to reference Looker KJ, Garnett GP. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect. 2005;81(2):103–7.CrossRefPubMedPubMedCentral Looker KJ, Garnett GP. A systematic review of the epidemiology and interaction of herpes simplex virus types 1 and 2. Sex Transm Infect. 2005;81(2):103–7.CrossRefPubMedPubMedCentral
31.
go back to reference Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV vaccine study group. N Engl J Med. 1999;341(19):1432–8.CrossRefPubMed Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV vaccine study group. N Engl J Med. 1999;341(19):1432–8.CrossRefPubMed
32.
go back to reference Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med. 1989;321(1):7–12.CrossRefPubMed Johnson RE, Nahmias AJ, Magder LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med. 1989;321(1):7–12.CrossRefPubMed
33.
go back to reference Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl. 1990;69:19–36.PubMed Nahmias AJ, Lee FK, Beckman-Nahmias S. Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl. 1990;69:19–36.PubMed
34.
go back to reference Lampert T, von der Lippe E, Muters S. Prevalence of smoking in the adult population of Germany: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(5–6):802–8.CrossRefPubMed Lampert T, von der Lippe E, Muters S. Prevalence of smoking in the adult population of Germany: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56(5–6):802–8.CrossRefPubMed
35.
go back to reference Patel R, Alderson S, Geretti A, Nilsen A, Foley E, Lautenschlager S, et al. European guideline for the management of genital herpes, 2010. Int J STD AIDS. 2011;22(1):1.CrossRefPubMed Patel R, Alderson S, Geretti A, Nilsen A, Foley E, Lautenschlager S, et al. European guideline for the management of genital herpes, 2010. Int J STD AIDS. 2011;22(1):1.CrossRefPubMed
36.
go back to reference Lara LA, Abdo CH. Age at time of initial sexual intercourse and health of adolescent girls. J Pediatr Adolesc Gynecol. 2016;29(5):417–23.CrossRefPubMed Lara LA, Abdo CH. Age at time of initial sexual intercourse and health of adolescent girls. J Pediatr Adolesc Gynecol. 2016;29(5):417–23.CrossRefPubMed
37.
go back to reference Aztlan-James EA, McLemore M, Taylor D. Multiple unintended pregnancies in U.S. women: a systematic review. Womens health issues. 2017. Aztlan-James EA, McLemore M, Taylor D. Multiple unintended pregnancies in U.S. women: a systematic review. Womens health issues. 2017.
38.
go back to reference Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964–73.CrossRefPubMed Xu F, Sternberg MR, Kottiri BJ, McQuillan GM, Lee FK, Nahmias AJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964–73.CrossRefPubMed
Metadata
Title
Decreasing seroprevalence of herpes simplex virus type 1 and type 2 in Germany leaves many people susceptible to genital infection: time to raise awareness and enhance control
Authors
Gerit Korr
Michael Thamm
Irina Czogiel
Christina Poethko-Mueller
Viviane Bremer
Klaus Jansen
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2017
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-017-2527-1

Other articles of this Issue 1/2017

BMC Infectious Diseases 1/2017 Go to the issue